Evidence Hub

Esophageal epithelial cell-derived kynurenine drives Th17 inflammation in reflux esophagitis and is targeted by Xuanfu Daizhe decoction

Jing Xun, Qi Gao, Huichao Yang, Jinlu Zhang, Yu Wang, B Liu, Xiaolin Jiang, Dihua Li et al.

Chinese Medicine, 2026

Abstract

BACKGROUND: The role of immunometabolic dysregulation in reflux esophagitis (RE), particularly the metabolic drivers of pathogenic T helper 17 (Th17) cell differentiation, is not fully understood. Although Xuanfu Daizhe Decoction (XDD) is a clinically effective Traditional Chinese Medicine (TCM) formula for RE, its potential to modulate these immunometabolic pathways remains unelucidated. OBJECTIVE: This study aimed to investigate the mechanism by which tryptophan metabolic dysregulation in RE influences Th17 cell differentiation and to evaluate whether XDD exerts therapeutic effects by targeting this pathway. METHODS: Metabolomic analysis was performed to assess alterations in the tryptophan metabolic pathway in serum from RE patients and RE rat models. Inflamed human esophageal epithelial cells (HEECs) model was established using acidified bile salts to observe kynurenine (KYN) secretion and its effect on Th17 differentiation. siRNA-mediated silencing of the aryl hydrocarbon receptor repressor (AHRR) was employed to clarify the role of AHRR in KYN-AhR-mediated Th17 differentiation. The interventional effects of XDD and its impact on the KYN-AHRR-AhR-Th17 axis were further examined in both cellular and rat models. RESULTS: Metabolomic profiling of clinical samples and RE rat models demonstrated significant dysregulation in the KYN pathway. Furthermore, we identified that inflamed HEECs induced high expression of IDO/TDO to elevate KYN secretion, which promoted Th17 cell…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free